---
reference_id: "PMID:35254878"
title: Type 1 Diabetes Mellitus.
authors:
- Syed FZ
journal: Ann Intern Med
year: '2022'
doi: 10.7326/AITC202203150
content_type: abstract_only
---

# Type 1 Diabetes Mellitus.
**Authors:** Syed FZ
**Journal:** Ann Intern Med (2022)
**DOI:** [10.7326/AITC202203150](https://doi.org/10.7326/AITC202203150)

## Content

1. Ann Intern Med. 2022 Mar;175(3):ITC33-ITC48. doi: 10.7326/AITC202203150. Epub 
2022 Mar 8.

Type 1 Diabetes Mellitus.

Syed FZ(1).

Author information:
(1)Duke University Division of General Internal Medicine, Durham, North 
Carolina.

Type 1 diabetes mellitus (T1DM) is an endocrine disorder in which pancreatic Î² 
cells stop producing insulin, typically due to autoimmune destruction. This 
results in hyperglycemia and ketosis; thus, insulin replacement is vital to 
management. Incidence peaks in puberty and early adulthood, but onset can occur 
at any age. However, prevalence is highest among adults because persons with 
T1DM live for many years. Symptoms include polyuria, polydipsia, and weight 
loss. Acute complications include diabetic ketoacidosis, which requires urgent 
management. Long-term complications include microvascular and macrovascular 
disease. Patients with T1DM are at higher risk for other autoimmune diseases and 
psychosocial issues. Management should focus on optimizing glucose control to 
reduce acute and long-term complications.

DOI: 10.7326/AITC202203150
PMID: 35254878 [Indexed for MEDLINE]